Boston Scientific Corp (NYSE:BSX), a $144.82 billion medical device manufacturer with strong financial health according to InvestingPro analysis, has received preliminary court approval for a ...
The aggregate gross proceeds to the Company from the offering are expected to be $1.83 million, before deducting the placement agent fees and other offering expenses payable by the Company. The ...